LEGN
Legend Biotech

1,013
Mkt Cap
$3.51B
Volume
1.8M
52W High
$45.30
52W Low
$16.24
PE Ratio
-14.55
LEGN Fundamentals
Price
$18.44
Prev Close
$19.00
Open
$18.54
50D MA
$20.10
Beta
0.51
Avg. Volume
3.13M
EPS (Annual)
-$0.9686
P/B
3.47
Rev/Employee
$240,534.92
$5,177.83
Loading...
Loading...
News
all
press releases
Westfield Capital Management Co. LP Lowers Stock Position in Legend Biotech Corporation Sponsored ADR $LEGN
Westfield Capital Management Co. LP trimmed its stake in Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN - Free Report) by 5.8% during the third quarter, according to its most recent 13F filing...
MarketBeat·5d ago
News Placeholder
More News
News Placeholder
Legend Biotech (NASDAQ:LEGN) Downgraded to "Hold" Rating by Truist Financial
Truist Financial lowered shares of Legend Biotech from a "strong-buy" rating to a "hold" rating in a research note on Monday...
MarketBeat·7d ago
News Placeholder
Legend Biotech (NASDAQ:LEGN) Shares Gap Up - Still a Buy?
Legend Biotech (NASDAQ:LEGN) Shares Gap Up - Here's Why...
MarketBeat·7d ago
News Placeholder
Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN) Given Average Rating of "Moderate Buy" by Brokerages
Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN - Get Free Report) has been given a consensus rating of "Moderate Buy" by the sixteen brokerages that are presently covering the firm, Marketbeat...
MarketBeat·18d ago
News Placeholder
Legend Biotech (NASDAQ:LEGN) Lowered to "Neutral" Rating by Rothschild & Co Redburn
Rothschild & Co Redburn downgraded shares of Legend Biotech from a "buy" rating to a "neutral" rating and set a $24.00 price target on the stock. in a report on Thursday...
MarketBeat·19d ago
News Placeholder
Legend Biotech (NASDAQ:LEGN) Sets New 12-Month Low - Time to Sell?
Legend Biotech (NASDAQ:LEGN) Hits New 1-Year Low - Time to Sell...
MarketBeat·27d ago
News Placeholder
82,516 Shares in Legend Biotech Corporation Sponsored ADR $LEGN Bought by Mutual of America Capital Management LLC
Mutual of America Capital Management LLC acquired a new position in Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN - Free Report) in the third quarter, according to the company in its most...
MarketBeat·30d ago
News Placeholder
Legend Biotech (NASDAQ:LEGN) Hits New 12-Month Low - Time to Sell?
Legend Biotech (NASDAQ:LEGN) Reaches New 52-Week Low - Here's What Happened...
MarketBeat·1mo ago
News Placeholder
Legend Biotech FY2025 EPS Estimate Lifted by HC Wainwright
Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN - Free Report) - Research analysts at HC Wainwright increased their FY2025 earnings per share estimates for shares of Legend Biotech in a report...
MarketBeat·1mo ago
News Placeholder
Legend Biotech (NASDAQ:LEGN) Shares Gap Down on Analyst Downgrade
Legend Biotech (NASDAQ:LEGN) Shares Gap Down After Analyst Downgrade...
MarketBeat·1mo ago
<
1
2
...
>

Latest LEGN News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.